Cardlytics Q3 revenue $52M (-22% YoY); net loss $72.7M, adj EBITDA positive $3.2M

Cardlytics, Inc.

2025-Q3 EPS reported -$1.81 vs consensus -$0.15 ▼ miss (-1083.0%)

Revenue $52.0M, down 22% YoY; net loss $72.7M ($1.36/share) improved from $145.2M loss in Q3 2024.
Adjusted EBITDA $3.2M vs $(1.8)M in Q3 2024; Adjusted Contribution $30.0M (down 17% YoY).
MQUs 230.3M (+21% YoY) but ACPU fell to $0.11 from $0.16.
Q4 guidance: Billings $86M-$96M, Revenue $51.1M-$59.1M, Adj EBITDA $0.9M-$7.9M.
CEO Amit Gupta cites 'decisive action to reset business' and return to growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.